The diabetes management experiences questionnaire: Psychometric validation among adults with type 1 diabetes
- PMID: 37562414
- DOI: 10.1111/dme.15195
The diabetes management experiences questionnaire: Psychometric validation among adults with type 1 diabetes
Abstract
Aims: To examine the psychometric properties of the Diabetes Management Experiences Questionnaire (DME-Q). Adapted from the validated Glucose Monitoring Experiences Questionnaire, the DME-Q captures satisfaction with diabetes management irrespective of treatment modalities.
Methods: The DME-Q was completed by adults with type 1 diabetes as part of a randomized controlled trial comparing hybrid closed loop (HCL) to standard therapy. Most psychometric properties were examined with pre-randomization data (n = 149); responsiveness was examined using baseline and 26-week follow-up data (n = 120).
Results: Pre-randomization, participants' mean age was 44 ± 12 years, 52% were women. HbA1c was 61 ± 11 mmol/mol (7.8 ± 1.0%), diabetes duration was 24 ± 12 years and 47% used an insulin pump prior to the trial. A forced three-factor analysis revealed three expected domains, that is, 'Convenience', 'Effectiveness' and 'Intrusiveness', and a forced one-factor solution was also satisfactory. Internal consistency reliability was strong for the three subscales ( range = 0.74-0.84) and 'Total satisfaction' = 0.85). Convergent validity was demonstrated with moderate correlations between DME-Q 'Total satisfaction' and diabetes distress (PAID: rs = -0.57) and treatment satisfaction (DTSQ; rs = 0.58). Divergent validity was demonstrated with a weak correlation with prospective/retrospective memory (PRMQ: rs = -0.16 and - 0.13 respectively). Responsiveness was demonstrated, as participants randomized to HCL had higher 'Effectiveness' and 'Total satisfaction' scores than those randomized to standard therapy.
Conclusions: The 22-item DME-Q is a brief, acceptable, reliable measure with satisfactory structural and construct validity, which is responsive to intervention. The DME-Q is likely to be useful for evaluation of new pharmaceutical agents and technologies in research and clinical settings.
Keywords: person-reported outcome; psychometric validation; treatment satisfaction; type 1 diabetes.
© 2023 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK.
References
REFERENCES
-
- TanenbaumML, HanesSJ, MillerKM, NaranjoD, BensenR, HoodKK. Diabetes device use in adults with type 1 diabetes: barriers to uptake and potential intervention targets. Diabetes Care. 2017;40:181-187.
-
- Gonder-FrederickLA, ShepardJA, GrabmanJH, RitterbandLM. Psychology, technology, and diabetes management. Am Psychol. 2016;71:577-589.
-
- McAuleySA, deBockMI, SundararajanV, et al. Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: a randomised controlled trial protocol. BMJ Open. 2018;8:e020274.
-
- SpeightJ, ChoudharyP, WilmotEG, et al. Impact of glycaemic technologies on quality of life and related outcomes in adults with type 1 diabetes: a narrative review. Diabet Med. 2023;40:e14944.
-
- Martin-DelgadoJ, GuilabertM, Mira-SolvesJ. Patient-reported experience and outcome measures in people living with diabetes: a scoping review of instruments. The Patient - Patient-Centered Outcomes Research. 2021;14:759-773.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
